Loading...
XNAS
HSCS
Market cap3mUSD
Jun 06, Last price  
3.58USD
1D
-0.28%
1Q
24.18%
IPO
47.93%
Name

Heart Test Laboratories Inc

Chart & Performance

D1W1MN
P/E
P/S
208.05
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
19k
+261.17%
64,18225,60414,3735,15018,600
Net income
-7m
L-98.65%
-3,833,822-2,581,173-4,578,060-490,854,290-6,605,208
CFO
-6m
L+5.14%
-3,839,995-2,452,294-3,644,144-5,773,577-6,070,185

Profile

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
IPO date
Jun 15, 2022
Employees
12
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑04
Income
Revenues
19
261.17%
5
-64.17%
Cost of revenue
2,885
2,464
Unusual Expense (Income)
NOPBT
(2,866)
(2,459)
NOPBT Margin
Operating Taxes
484,500
Tax Rate
NOPAT
(2,866)
(486,959)
Net income
(6,605)
-98.65%
(490,854)
10,621.88%
Dividends
Dividend yield
Proceeds from repurchase of equity
10,300
5,624
BB yield
-31,621.47%
-7,970.54%
Debt
Debt current
602
530
Long-term debt
970
1,602
Deferred revenue
Other long-term liabilities
187
Net debt
(4,235)
471
Cash flow
Cash from operating activities
(6,070)
(5,774)
CAPEX
(64)
(18)
Cash from investing activities
(125)
(18)
Cash from financing activities
10,343
6,534
FCF
(3,232)
(487,505)
Balance
Cash
5,808
1,660
Long term investments
Excess cash
5,807
1,660
Stockholders' equity
(67,361)
(61,128)
Invested Capital
75,715
62,488
ROIC
ROCE
EV
Common stock shares outstanding
353
80
Price
0.09
-89.59%
0.89
 
Market cap
33
-53.84%
71
 
EV
(4,202)
542
EBITDA
(2,771)
(2,432)
EV/EBITDA
1.52
Interest
354
243
Interest/NOPBT